Parib Capsule 50 mg contains Olaparib, a targeted cancer therapy belonging to the class of poly (ADP-ribose) polymerase (PARP) inhibitors. It is designed to interfere with DNA repair mechanisms within cancer cells, resulting in controlled cell death and reduced tumor progression. Parib is commonly prescribed for specific types of advanced cancers, especially those associated with BRCA gene mutations.
This medication represents a modern approach in oncology, offering both disease control and improved quality of life for patients who meet the treatment criteria. Parib Capsule 50 mg is typically used under the supervision of an oncologist and is an essential component in the personalized treatment of particular breast and ovarian cancers.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient: Olaparib
Strength: 50 mg per capsule
Dosage Form: Oral capsule
Therapeutic Class: PARP inhibitor / Antineoplastic agent
Manufacturer: SK Pharma
Parib targets and inhibits the PARP enzyme, which helps cancer cells repair damaged DNA. In cancers with defective DNA repair pathways (such as those with BRCA1 or BRCA2 mutations), inhibiting PARP prevents the tumor cells from fixing DNA damage. This leads to accumulation of DNA damage and ultimately promotes cancer cell death while sparing normal cells. By blocking these repair mechanisms, Parib selectively targets cancer cells and slows disease progression.
Parib Capsule 50 mg is indicated for the treatment of:
Ovarian cancer
Breast cancer
Other BRCA-mutated malignancies (as determined by oncologist and genetic testing)
It may be used as monotherapy or in combination with other treatments depending on patient condition and oncologist decision. Prescription and therapeutic monitoring by healthcare professionals are essential for safe and effective use.
Treatment with Parib Capsule 50 mg must be individualized based on patient condition, response, and tolerability. Typically:
Administered orally, usually twice daily
Take at the same time each day to maintain consistent drug levels
May be administered with or without food
Do not crush or chew capsules
Always follow the exact dosing instructions provided by a licensed healthcare provider. Dose modifications may be necessary in patients experiencing side effects, or with kidney or liver impairment.
Like all cancer therapies, Parib may cause side effects. Commonly reported adverse reactions include:
Fatigue
Nausea and vomiting
Headache
Anemia and other blood count changes
Diarrhea or constipation
Regular blood tests and clinical evaluations are recommended to monitor treatment response and detect potential toxicities early. Patients should report any unusual symptoms or persistent discomfort to their physician promptly.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Before starting Parib:
Inform your doctor of all medications, supplements, or herbal products being taken
Discuss any history of liver or kidney disease
Pregnancy and breastfeeding should be avoided during treatment due to potential fetal harm
Offers targeted cancer treatment with a mechanism focused on BRCA-related DNA repair deficiency
Can provide disease stabilization and prolonged progression-free survival
Oral dosing offers convenience compared to intravenous chemotherapy.
Login Or Registerto submit your questions to seller
No none asked to seller yet